These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19336395)

  • 21. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment.
    Jura N; Endres NF; Engel K; Deindl S; Das R; Lamers MH; Wemmer DE; Zhang X; Kuriyan J
    Cell; 2009 Jun; 137(7):1293-307. PubMed ID: 19563760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidermal growth factor (EGF) induces oligomerization of soluble, extracellular, ligand-binding domain of EGF receptor. A low resolution projection structure of the ligand-binding domain.
    Lax I; Mitra AK; Ravera C; Hurwitz DR; Rubinstein M; Ullrich A; Stroud RM; Schlessinger J
    J Biol Chem; 1991 Jul; 266(21):13828-33. PubMed ID: 1856216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.
    Ferguson KM; Berger MB; Mendrola JM; Cho HS; Leahy DJ; Lemmon MA
    Mol Cell; 2003 Feb; 11(2):507-17. PubMed ID: 12620237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.
    Scheck RA; Lowder MA; Appelbaum JS; Schepartz A
    ACS Chem Biol; 2012 Aug; 7(8):1367-76. PubMed ID: 22667988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensification of growth factor receptor signalling by phorbol treatment of ligand-primed cells implies a dimer-stabilizing effect of protein kinase C-dependent juxtamembrane domain phosphorylation.
    Gulliford T; Ouyang X; Epstein RJ
    Cell Signal; 1999 Apr; 11(4):245-52. PubMed ID: 10372802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
    Fan YX; Wong L; Deb TB; Johnson GR
    J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling.
    Pascarelli S; Merzhakupova D; Uechi GI; Laurino P
    J Biol Chem; 2021 Jul; 297(1):100872. PubMed ID: 34126069
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGF induces increased ligand binding affinity and dimerization of soluble epidermal growth factor (EGF) receptor extracellular domain.
    Hurwitz DR; Emanuel SL; Nathan MH; Sarver N; Ullrich A; Felder S; Lax I; Schlessinger J
    J Biol Chem; 1991 Nov; 266(32):22035-43. PubMed ID: 1657987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The extracellular domain of the epidermal growth factor receptor. Studies on the affinity and stoichiometry of binding, receptor dimerization and a binding-domain mutant.
    Brown PM; Debanne MT; Grothe S; Bergsma D; Caron M; Kay C; O'Connor-McCourt MD
    Eur J Biochem; 1994 Oct; 225(1):223-33. PubMed ID: 7925442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational stability of the epidermal growth factor (EGF) receptor as influenced by glycosylation, dimerization and EGF hormone binding.
    Taylor ES; Pol-Fachin L; Lins RD; Lower SK
    Proteins; 2017 Apr; 85(4):561-570. PubMed ID: 28019699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional and structural stability of the epidermal growth factor receptor in detergent micelles and phospholipid nanodiscs.
    Mi LZ; Grey MJ; Nishida N; Walz T; Lu C; Springer TA
    Biochemistry; 2008 Sep; 47(39):10314-23. PubMed ID: 18771282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging phosphorylation dynamics of the epidermal growth factor receptor.
    Offterdinger M; Georget V; Girod A; Bastiaens PI
    J Biol Chem; 2004 Aug; 279(35):36972-81. PubMed ID: 15215236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization of a receptor reserve for effective amplification of mitogenic signaling by an epidermal growth factor mutant deficient in receptor activation.
    Nandagopal K; Popp DM; Niyogi SK
    J Cell Biochem; 2001 Aug 1-9; 83(2):326-41. PubMed ID: 11573249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exogenous ganglioside GD1a enhances epidermal growth factor receptor binding and dimerization.
    Liu Y; Li R; Ladisch S
    J Biol Chem; 2004 Aug; 279(35):36481-9. PubMed ID: 15215248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.
    Yang KS; Ilagan MX; Piwnica-Worms D; Pike LJ
    J Biol Chem; 2009 Mar; 284(12):7474-82. PubMed ID: 19171934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative constraints underlie the ErbB specificity of epidermal growth factor-like ligands.
    van der Woning SP; van Rotterdam W; Nabuurs SB; Venselaar H; Jacobs-Oomen S; Wingens M; Vriend G; Stortelers C; van Zoelen EJ
    J Biol Chem; 2006 Dec; 281(52):40033-40. PubMed ID: 17032651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
    Kang S; Dong S; Guo A; Ruan H; Lonial S; Khoury HJ; Gu TL; Chen J
    J Biol Chem; 2008 Feb; 283(8):4652-7. PubMed ID: 18156174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling.
    Broome MA; Hunter T
    J Biol Chem; 1996 Jul; 271(28):16798-806. PubMed ID: 8663329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.
    Lax I; Bellot F; Honegger AM; Schmidt A; Ullrich A; Givol D; Schlessinger J
    Cell Regul; 1990 Jan; 1(2):173-88. PubMed ID: 2100196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the EGF receptor by binding of MIG6 to an activating kinase domain interface.
    Zhang X; Pickin KA; Bose R; Jura N; Cole PA; Kuriyan J
    Nature; 2007 Nov; 450(7170):741-4. PubMed ID: 18046415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.